Arbutus Biopharma Corp

ABUS · Nasdaq · SIC 2834: Pharmaceutical Preparations
523
SEC Filings

Business Summary

PART I Overview Arbutus Biopharma Corporation (Arbutus, the Company, we, us, and our) is a clinical-stage biopharmaceutical company focused on infectious disease. We are currently developing imdusiran (AB-729), our proprietary, GalNAc-conjugated, subcutaneously-delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, our proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). We continue to protect and defend our intellectual property, which is the subje...

Next Earnings

Q2 FY2026 — expected 2026-09-07

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionABUSdiscussed_in_filing Artificial Intelligence
topic_mentionABUSdiscussed_in_filing Cybersecurity
topic_mentionABUSdiscussed_in_filing Trusted Computing
topic_mentionABUSdiscussed_in_filing Blockchain & Crypto
topic_mentionABUSdiscussed_in_filing Regulation
topic_mentionABUSdiscussed_in_filing Healthcare & Bio
topic_mentionABUSdiscussed_in_filing Sovereign & Government
topic_mentionABUSdiscussed_in_filing Artificial Intelligence
topic_mentionABUSdiscussed_in_filing Cybersecurity
topic_mentionABUSdiscussed_in_filing Trusted Computing
topic_mentionABUSdiscussed_in_filing Blockchain & Crypto
topic_mentionABUSdiscussed_in_filing Regulation
topic_mentionABUSdiscussed_in_filing Healthcare & Bio
topic_mentionABUSdiscussed_in_filing Sovereign & Government
topic_mentionABUSdiscussed_in_filing Artificial Intelligence
topic_mentionABUSdiscussed_in_filing Cybersecurity
topic_mentionABUSdiscussed_in_filing Trusted Computing
topic_mentionABUSdiscussed_in_filing Blockchain & Crypto
topic_mentionABUSdiscussed_in_filing Regulation
topic_mentionABUSdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001447028-26-000017EDGAR66K words
2025-03-272024-12-310001447028-25-000083EDGAR—
2024-03-052023-12-310001447028-24-000035EDGAR—
2023-03-022022-12-310001447028-23-000018EDGAR—
2022-03-032021-12-310001447028-22-000019EDGAR—
2021-03-042020-12-310001447028-21-000021EDGAR—
2020-03-052019-12-310001447028-20-000038EDGAR—
2019-03-072018-12-310001447028-19-000006EDGAR—
2018-03-162017-12-310001628280-18-003276EDGAR—
2017-03-222016-12-310001628280-17-002760EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001447028-25-000126EDGAR24K words
2025-08-062025-06-300001447028-25-000115EDGAR—
2025-05-142025-03-310001447028-25-000099EDGAR—
2024-11-062024-09-300001447028-24-000087EDGAR—
2024-08-082024-06-300001447028-24-000072EDGAR—
2024-05-022024-03-310001447028-24-000038EDGAR—
2023-11-072023-09-300001447028-23-000090EDGAR—
2023-08-032023-06-300001447028-23-000082EDGAR—
2023-05-042023-03-310001447028-23-000025EDGAR—
2022-11-092022-09-300001447028-22-000055EDGAR—
2022-08-042022-06-300001447028-22-000047EDGAR—
2022-05-052022-03-310001447028-22-000025EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-230001171843-26-001838EDGAR3K words
2026-03-030001171843-26-001299EDGAR—
2026-02-200001171843-26-000979EDGAR—
2026-02-060001171843-26-000676EDGAR—
2026-01-160001171843-26-000303EDGAR—
2025-12-110001171843-25-007879EDGAR—
2025-11-130001171843-25-007256EDGAR—
2025-10-070001171843-25-006316EDGAR—
2025-09-100001171843-25-005815EDGAR—
2025-08-060001171843-25-005076EDGAR—

523 total filings indexed. 491 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001447028
TickerABUS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedA1

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: dae2ceba6436d28d4a24d4b08fde407092cf71c21be8d9b536ae1d6e5bfa819e
parent: 5ea77b7d19846ec0229048acbe7d2c4daab9371cde0c53c51a288888f2a12d70
content hash: 06eb18ffc75dd2274addb959cbdbbf913de3cce414a174addd2ff1a590ed3ed4
signed: 2026-04-13T04:43:25.511Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf